SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-015309
Filing Date
2016-11-21
Accepted
2016-11-21 12:47:51
Documents
41
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 493585
2 ex31-1.htm EX-31.1 13905
3 ex32-1.htm EX-32.1 7493
  Complete submission text file 0001493152-16-015309.txt   2716627

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20160930.xml EX-101.INS 497100
5 XBRL SCHEMA FILE mrna-20160930.xsd EX-101.SCH 29207
6 XBRL CALCULATION FILE mrna-20160930_cal.xml EX-101.CAL 26087
7 XBRL DEFINITION FILE mrna-20160930_def.xml EX-101.DEF 130849
8 XBRL LABEL FILE mrna-20160930_lab.xml EX-101.LAB 204746
9 XBRL PRESENTATION FILE mrna-20160930_pre.xml EX-101.PRE 171698
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 162009724
SIC: 2834 Pharmaceutical Preparations